Home Page - 2026 Binaytara Northwest Women's Cancer Conference

The 2026 Binaytara Northwest Women's Cancer Conference is a CME-accredited educational activity bringing together expert faculty in breast cancer and gynecologic malignancies. Designed for a multidisciplinary oncology audience, this conference provides a focused forum for examining the most recent scientific findings and practice-changing advances shaping the care of women with cancer.

The program features in-depth discussion and critical analysis of emerging data across the full spectrum of women's cancers — from novel therapeutic strategies and updated clinical trial results to the evolving role of precision oncology in routine clinical practice. Expert faculty will place different therapeutic agents in clinical context, helping attendees understand how to integrate new evidence into individualized patient care.

This activity is designed to improve the knowledge and competence of healthcare professionals to apply practice-changing clinical data and expert recommendations — optimizing clinical outcomes for patients with breast cancer and gynecologic malignancies, and augmenting participants' overall foundation in the management of women's cancers.

Attendees will leave with a strengthened command of current treatment guidelines, a deeper understanding of biomarker-driven therapy selection, and practical strategies for incorporating the latest evidence into their clinical decision-making.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Embassy Suites by Hilton Portland Downtown